How effective is Kapecitabine for breast cancer?

Capecitabine for breast cancer can potentially extend survival times and reduce the chance of recurrence. This drug was originally developed and approved for use in cases of advanced breast metastatic cancer, where the patient did not respond to earlier chemotherapy. The following clinical studies show that in some cases the first line treatment can be used and may be useful in the therapy of early breast cancer to reduce the risk of recurrence. It is designed for use as an auxiliary agent in conjunction with other chemotherapy medicines such as docetaxel.

This drug selectively attacks and kills tumor cells. It tends to be less reactive with other medicines than some chemotherapeutic drugs, although it may come up with side effects such as nausea and diarrhea. Patients take medicines orally, which may be consideration for patients who consider intravenous infusion unpleasant. The length of time during chemotherapy and the number of courses needed depends on cancer. The average survival rate is longer than the DoceTaxel, which shows that this medicine has clear benefits for breast cancer patients. In 2009, Finnish scientists also noted that it has advantages for patients with early breast cancer and could be added to chemotherapeutic regimens to reduce the chances of recurrence.

Estrogen receptor (ER) positive tumors tend to respond more significantly to breast cancer. Patients with cancer diagnosis may undergo some testing to learn more about the specific nature of the tumor, including the ER cancer checks. This can allow doctors to recommend the best course of chemotherapy for the patient's situation, given which drugs are most likely Effective. In cases where cancer is not positive, other chemotherapy medicines may be a better choice and the rate of success on kapecitabine may be lower than in other patient populations.

breast cancer research is constantly inYou have a youth field. Clinical studies using breast cancer and patients interested in contributing to research may apply for access to new medicines with drugs. This can help discuss all the treatment options for cancer with a physician before committing a specific treatment plan, because Kapecitabine for breast cancer may not be the only or best selection. Oncologists can also provide recommendations for second opinions if patients want to talk to another doctor about available methods of treatment.